Avanos Medical (AVNS) Net Margin (2013 - 2026)

Avanos Medical (AVNS) has 12 years of Net Margin data on file, last reported at 2.8% in Q1 2026.

• For the quarter ending Q1 2026, Net Margin changed N/A year-over-year to 2.8%; the trailing twelve-month figure through Mar 2026 stood at 0.71% (up 135.0% YoY), and the FY2024 full-year result was 0.84%, up 687.0% from the prior year.
• Net Margin advanced to 2.8% in Q1 2026, from 0.17% in the prior quarter.
• In the past five years, Net Margin ranged from a high of 4.58% in Q1 2023 to a low of 37.66% in Q2 2023.
• A 4-year average of 1.31% and a median of 2.73% in 2022 frame the typical range for Net Margin.
• Across the five-year window, Net Margin surged 7575 bps in 2022 and slumped 4217 bps in 2023, its largest moves.
• Tracing AVNS's Net Margin over 4 years: stood at 3.96% in 2022, then sank by 107 bps to 0.29% in 2023, then soared by 42 bps to 0.17% in 2024, then surged by 1776 bps to 2.8% in 2026.
• Business Quant data shows AVNS's Net Margin at 2.8% in Q1 2026, 0.17% in Q4 2024, and 0.94% in Q3 2024.